Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
aBM-MSCs for Alveolar Crestal Bone Preservation
NCT03070275Phase 2Completed
- Sponsor
- Aristotle University of Thessaloniki
- Start
- Feb 2015
- Primary completion
- Jun 2017
- Modality
- Stem Cell Therapies
01
Overview
A Phase 2 trial of autologous alveolar bone marrow mesenchymal stem cells in Alveolar bone loss, sponsored by Aristotle University of Thessaloniki. Started Feb 2015; status: completed.
02
Drugs
autologous alveolar bone marrow mesenchymal stem cells
03
Conditions
Alveolar bone loss
Beyond the preview
Go deeper on NCT03070275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03070275.